-
Xencor Sees Profit-Taking After Big Pre-Market Spike
Tuesday, March 8, 2016 - 1:11pm | 396Read More...Xencor Inc (NASDAQ: XNCR) is on a roll this week, having announced Q4 2015 earnings beats Monday and initiating Phase II trials for its XmAb®5871 on two patients, one with IgG4-Related Disease and another with Systemic Lupus Erythematosus. The stock saw significant movement upward in...
-
Vertex Is Poised For An Earnings Breakout
Wednesday, July 23, 2014 - 3:56pm | 429Read More...Earnings season is in full effect with some of the big hitters already hitting the tape. This last week has given us results from the likes of Microsoft (NASDAQ: MSFT), Google (NASDAQ: GOOGL) and Apple (NASDQ: AAPL). On Wednesday morning one of biotechs big hitters, Biogen Idec (NASDAQ: BIIB...
-
Alzheimer's Rates Falling, But Pharma's Search For A Cure Yields No Results
Thursday, July 17, 2014 - 11:12am | 691Read More...Mixed news came out this week on research into Alzheimer's. New studies suggest the rate of Alzheimer's and other forms of dementia is dropping in the United States and other developed countries. Meanwhile, Big Pharma's years-long battle to find a treatment, if not a cure,...
